Analyst consensus rating
Eloxx Pharmaceuticals Analyst Rating: Strong Buy
Direct answer
Eloxx Pharmaceuticals's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $40.33.
Forecast evidence checked September 5, 2026.
Get free Eloxx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $15.00
- Average price target
- $40.33
- High price target
- $43.00
- Low price target
- $38.00
- Low target gap
- +153.3%
- Target upside
- +168.9%
- High target gap
- +186.7%
- Target range width
- 33.3%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- September 5, 2026
- Valid through
- September 12, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $40.33.
How far are Eloxx Pharmaceuticals's low and high targets from the recorded price?
The low target implies +153.3%, while the high target implies +186.7%.
How many analysts are included in Eloxx Pharmaceuticals's consensus?
The verified consensus includes 3 analysts.
How is Eloxx Pharmaceuticals's target upside or downside calculated?
The average target of $40.33 is divided by the recorded price of $15.00, then one is subtracted to produce +168.9%. This does not guarantee a future return.
When was Eloxx Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-09-05. The dataset is valid through 2026-09-12.